TLR-mediated B cell activation results in ectopic CLIP expression that promotes B cell-dependent inflammation

Area of Science:

• Immunology
• Molecular Biology
• Genetics

Background:

• Toll ligands activate Toll-like receptors (TLRs) on lymphocytes, initiating innate immune responses.
• Failure to control acute inflammation can lead to chronic post-infectious inflammation, linked to MHC genes.
• B lymphocyte depletion therapies show promise in dampening chronic immune activation in autoimmune diseases.

Purpose of the Study:

• To elucidate the mechanism linking TLR activation, MHC genetics, and the pathological role of B-lymphocytes in chronic inflammation.
• To investigate the hypothesis that improperly controlled TLR-activated B cells cause chronic inflammation.

Main Methods:

• Treatment of cells with Toll ligands to induce polyclonal B cell activation.
• Adoptive transfer of purified CLIP+ B cells into syngeneic animals.
• CLIP-targeted peptide competition to induce B cell death.

Main Results:

• Toll ligand treatment induced polyclonal B cell activation and ectopic CLIP expression.
• CLIP+ B cells stimulated TNF-α production in host T cells.
• CLIP-targeted peptide competition led to the death of polyclonally activated CLIP+ B cells.

Conclusions:

• TLR-activated B cells, characterized by CLIP expression, contribute to chronic inflammation by engaging T cells.
• Targeting CLIP on these B cells offers a potential therapeutic approach to eliminate them and resolve chronic inflammation.